Local NewsBusiness GT Biopharma Announces Pricing of $23,650,000 Public Offering and Uplisting to The Nasdaq Capital Market By Digital AIM Web Support - February 11, 2021 FacebookTwitterPinterestWhatsApp Like this:Like Loading... Related Featured Local Savings Featured Local Savings